19-46411337-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_032040.5(CCDC8):c.1474C>T(p.Arg492Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032040.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC8 | NM_032040.5 | c.1474C>T | p.Arg492Cys | missense_variant | 1/1 | ENST00000307522.5 | NP_114429.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC8 | ENST00000307522.5 | c.1474C>T | p.Arg492Cys | missense_variant | 1/1 | 6 | NM_032040.5 | ENSP00000303158.3 | ||
CCDC8 | ENST00000697726.1 | c.1684C>T | p.Arg562Cys | missense_variant | 1/1 | ENSP00000513420.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251430Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135906
GnomAD4 exome AF: 0.0000629 AC: 92AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000701 AC XY: 51AN XY: 727248
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74464
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.1474C>T (p.R492C) alteration is located in exon 1 (coding exon 1) of the CCDC8 gene. This alteration results from a C to T substitution at nucleotide position 1474, causing the arginine (R) at amino acid position 492 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 08, 2021 | Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The cysteine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with CCDC8-related conditions. This variant is present in population databases (rs532222986, ExAC 0.04%). This sequence change replaces arginine with cysteine at codon 492 of the CCDC8 protein (p.Arg492Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at